Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
3
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
3
×
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
teva pharmaceutical
3
×
texas blog main
texas top stories
3
×
wisconsin blog main
wisconsin top stories
amgen
calcitonin gene-related peptide
drugs
eli lilly
eptinezumab
erenumab
fremanezumab
galcanezumab
migraine research foundation
acute myeloid leukemia
What
fda
3
×
approval
class
drug
drugs
migraine
new
won
ahead
amgen
arguments
asco
big
bio
branded
candidates
choices
commercialized
commissioner
companies
competitors
consumers
costly
counterweight
decades
developed
elevatebio
generic
gets
graft
head
make
medications
medicines
meeting
neuro
nod
oral
pain
potential
Language
Current search:
fda
×
fda
×
" texas top stories "
×
" raleigh-durham blog main "
×
" teva pharmaceutical "
×
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines